The Open Targets Blog

APRIL 25, 2023

My impression from their testimonies is that they must have felt a great sense of a common purpose and the importance of their work, despite the necessary secrecy and sometimes drudgery involved. A diverse group of people were recruited to Bletchley Park. ranging from university academics through engineers and clerical staff to the military.

DNA 52

DNA Government Engineering Laboratories 52

The Pharma Data

MAY 14, 2021

For more information on Scott Sonnon, please visit his blog. All testimonials on this site are real. Required Legal Disclaimer: Due to recent laws from the FTC, it is required that all companies identify what a “typical” result is. However, the results described are meant as a showcase of what the best, most motivated.

Packaging 52

Packaging Production Doctors International 52

The Pharma Data

MAY 14, 2021

testimonials that my happy customers have graciously sent me from. story or testimonial to tell me about the results you’ve achieved – and. Testimonials. | The information provided here is PROVEN to work for any man or woman at any age looking for an easy and effective way to cure Shingles. on its own. I’ve.

Treatment 52

Treatment Doctors Virus Vaccine 52

Agency IQ

MARCH 1, 2024

Per a statement from a 2014 shutdown (which has been scrubbed from the FDA’s web pages, but was captured in this FDA Law Blog article ), the agency “will not be able to accept any regulatory submissions… that require a fee payment and that are submitted during the lapse period.” What happens in the longer term?

Government 40

Government FDA Biosimilars Regulations 40

The Pharma Data

MAY 13, 2021

I have been in contact with Rick for only a few months now, but his Muscle Imbalances Revealed DVDs and blog have really helped me out immensely. Physical Therapist and Athletic Trainer. Former New England Revolution Therapist / Trainer. “I He has a way of bringing his knowledge across very efficient and effectively. And I think itâ??s

Production 52

Production Treatment Vaccine Therapies 52

FDA Law Blog: Biosimilars

JULY 21, 2024

In alleging that antibiotic use was a public health problem that FDA should regulate, the plaintiffs offered several testimonials from ostensibly affected people. Alliance for Nurses started as a Citizen’s Petition back in 2016, making its way to District Court when FDA took no action.

Nurses 59

Nurses FDA Testimonials Doctors 59

FDA Law Blog: Biosimilars

APRIL 8, 2024

In 2022, the Government Accountability Office (GAO) reported that FDA needed to improve its foreign inspection program and that report prompted a hearing on Capitol Hill in February of this year where HPM Counsel John Claud offered testimony.

Drugs 59

Drugs FDA Hospitals Government 59

FDA Law Blog: Biosimilars

MARCH 14, 2023

Merrick Garland, Testimony Before the Senate Judiciary Committee, Mar. AG Garland concluded that he anticipates DOJ’s cannabis policy will be consistent with what he said during his confirmation in that “it will be very close” to the Cole Memorandum. 1, 2023 ( 02:38:46 ).

Testimonials 45

Testimonials Regulations Compliance Drugs 45

FDA Law Blog: Biosimilars

FEBRUARY 18, 2025

Hull A recent DEA decision revoking the registration of a Louisiana pharmacy sheds light on the Agencys approach to crediting one experts testimony over that of another expert during an administrative hearing. The hearing involved dueling expert testimony on the pharmacy standard of care in Louisiana from both DEA and the respondent.

Testimonials 69

Testimonials Pharmacy Government Drugs 69

FDA Law Blog: Biosimilars

NOVEMBER 26, 2024

No witness testimony will be offered nor received on Monday. The “preliminary hearing,” which will begin Monday, December 2nd at 9:30 a.m. in DEA’s North Courtroom at its headquarters in Arlington, Virginia, will serve to address legal and logistical issues and future dates for the evidentiary hearing on the merits.

Engineering 75

Engineering Testimonials Drugs 75

Perficient: Drug Development

DECEMBER 18, 2024

In this blog, well explore the most impactful features of React 19 with examples to understand how they change, the way we build React applications. If CourseWrapper takes longer to receive its data, CourseList and Testimonials cannot render until CourseWrapper completes. Key Features of React 19 1.

Testimonials 52

Testimonials Production 52

FDA Law Blog: Biosimilars

MARCH 24, 2025

In January a public hearing began to receive factual evidence and testimony on whether marijuana should be rescheduled. DEA published a Notice of Proposed Rulemaking (NPRM), signed by Attorney General Merrick Garland, proposing to reschedule marijuana in May 2024 that elicited over 43,500 comments.

Regulations 64

Regulations Testimonials Licensing Licensing 64

Conversations in Drug Development Trends

OCTOBER 29, 2024

These meetings are designed for attendees to hear testimonies from clinicians, patients, caregivers, and families about the issues facing these stakeholder groups in the diagnosis, treatment, and long-term prognosis of a disease as it is experienced in real life – not through an impersonal, peer-reviewed case report.

Clinical Research 72

Clinical Research Disease Research Clinical Trials 72

FDA Law Blog: Biosimilars

OCTOBER 24, 2024

Gibbs — A recent blog post focused on the potentially negative implications of the proposed Patent Eligibility Restoration Act (PERA) for manufacturers of generic drugs and biosimilar products. Javitt & Jeffrey N. The concerns raised by PERA are not limited to these industries, however.

Laboratories 64

Laboratories DNA Testimonials Production 64

Codon

JUNE 2, 2024

In a testimony in front of the U.S. In his spare time he enjoys blogging about biotechnology. While the use of inbred mice was initially constrained to research on the genetics of implanted tumors, the research applications of the lab mouse expanded greatly following a 1938 grant from the newly established National Cancer Institute.

Laboratories 127

Laboratories Research Disease Science 127

Perficient: Drug Development

JANUARY 14, 2025

Check out my previous blog on Micro-Moments in E-Commerce ], where I break down the strategies and tools you can use to make personalization a cornerstone of your business. AI-powered platforms make this easier than ever, helping you predict client needs and meet them proactively. Want to explore this topic in more detail?

Marketing 52

Marketing Testimonials Production Research 52

FDA Law Blog: Biosimilars

DECEMBER 11, 2024

Weve railed against passage of the BLOCKING Act since February 2018 when it was made as a legislative proposal in the first Trump Administrations Proposed Fiscal Year 2019 Budget (pages 22 and 51)including in blog posts ( here , here , here , here , and here ) and in Congressional testimony as antithetical to a primary goal of the Hatch-Waxman Amendments: (..)

Packaging 64

Packaging Testimonials Drugs Drug Development 64

Drug & Device Law

MARCH 4, 2024

Plaintiffs will not be heard to argue that they “could have shored up their cases by other means had they known their expert testimony would be found inadmissible.” His inability to produce admissible expert testimony is due to his own actions, namely the failure of his proposed experts to test their alternatives. Weisgram v.

Testimonials 52

Testimonials Production Vaccine Pharmaceuticals 52

Drug & Device Law

FEBRUARY 20, 2024

This post is not from the Reed Smith or Holland & Knight sides of the blog. Nor did the court find persuasive cases in which other courts left open the possibility that the treating physician may have at some time reviewed the IFU because here the surgeon’s testimony left no room for doubt. 2024 WL 385108 (S.D.

Testimonials 52

Testimonials Production FDA 52

Drug & Device Law

FEBRUARY 16, 2024

The Dearinger case in the Western District of Washington provided a lot of defense friendly blog fodder. We blogged about that decision here. Plaintiffs provided testimony from that physician suggesting that he would have changed his prescribing decision if presented with plaintiffs’ proposed warning language. Allied Mut.

Testimonials 52

Testimonials FDA Approval FDA Doctors 52

Drug & Device Law

FEBRUARY 11, 2024

We’ve blogged several times already about the Alliance for Hippocratic Medicine v. 19, 2021) (admitting and excluding Studnicki testimony); Whole Woman’s Health Alliance v. FDA litigation that is now before the Supreme Court. See , e.g. , Whole Woman’s Health Alliance v. Rokita , 2021 WL 650589, at *12-17 (Mag.

FDA 59

FDA Production FDA Approval Regulations 59

Drug & Device Law

JANUARY 5, 2024

I am excited to join the Drug & Device Law Blogging Team. A more fulsome discussion of the Washington Supreme Court’s answer is on the Blog. Plaintiffs had no evidence to rebut the treater’s clear testimony. For readers noticing the new byline, let me introduce myself. The best group of legal wonks there is.

Testimonials 52

Testimonials Production Doctors Pharmaceuticals 52

Drug & Device Law

DECEMBER 29, 2023

2023) (remote trial testimony cannot be compelled beyond Rule 45’s 100-mile limit on subpoenas) ( here ); Carson v. This year’s Drug & Device Law Blog top ten decisions of the year reinforced preemption – the most powerful defense we can assert. They excluded bogus expert testimony under Fed. Bonta , 85 F.4th Monsanto Co. ,

Testimonials 105

Testimonials Drugs FDA Vaccine 105

Drug & Device Law

DECEMBER 26, 2023

As readers of the Blog undoubtedly know , the amendments toughening up Fed. Testimony by expert witnesses. But it remains the case that other admissibility requirements in the rule (such as that the expert must be qualified and the expert’s testimony must help the trier of fact) are governed by the Rule 104(a) standard as well.

Testimonials 52

Testimonials Government Production Pharmaceuticals 52

Drug & Device Law

DECEMBER 20, 2023

We are even more likely to blog about a case if it follows up on an earlier decision about which we scribbled. We have blogged about this prosecution twice before. When we represented the United States of America, we were often in court, often on our own, and yet often dealing from positions of strength.

Trials 52

Trials FDA Production Testimonials 52

Drug & Device Law

NOVEMBER 27, 2023

Thus, when the other side inveigles one of ours to switch sides – usually with the promise of a lot more money for a lot more testimony – the result can be a lot of collateral litigation. We’ve blogged a couple of times before about turncoat experts, so the recent decision in Hawkins v. DePuy Orthopaedics, Inc. 2023 WL 7292164 (D.D.C.

Testimonials 96

Testimonials Production Engineering Science 96

Drug & Device Law

OCTOBER 11, 2023

The Blog has compiled an “ E-Discovery for Defendants Cheat Sheet ” (yes, we know, it needs updating) of decisions favoring defendants seeking discovery of plaintiffs’ social media activity. We searched, and the word “medical,” and it doesn’t appear anywhere in LCJ’s thirty-plus page submission. We also have another concern. 3d 520 (M.D.N.C.

Testimonials 59

Testimonials Production International Trials 59

Drug & Device Law

OCTOBER 9, 2023

We’ve discussed our Drug and Device Law Blog elder care duties before and how it has educated us about health issues faced by the senior population. Because Dr. Jeret did not employ reliable methods in reaching his general or specific causation opinions, his testimony was excluded.

Vaccine 59

Vaccine Testimonials Virus Production 59

Drug & Device Law

AUGUST 2, 2023

In addition, we blogged about the district court order here. The district court ruled that the three plaintiffs experts flunked the Rule 702 analysis and then granted summary judgment to the defendant because the absence of admissible expert testimony on general causation sunk the case.

Science 52

Science Testimonials Compliance Pharmaceuticals 52

Drug & Device Law

JUNE 23, 2023

We’ve blogged before about the plaintiffs’ self-defeating “injury” definition in the Taxotere mass tort litigation. Plaintiff Adams’ “sworn testimony and plaintiff fact sheet” established that she blew the statute of limitations by some eight years. This wasn’t a close case. at *34-35.

Testimonials 59

Testimonials Government Treatment Production 59

Drug & Device Law

JUNE 20, 2023

Since 2018, we have blogged several times about the federal government’s crackdown on abusive False Claims Act (“FCA”) litigation via motions for dismissal, and how the abusive relators have tried to resist those efforts.

Government 59

Government Testimonials 59

Drug & Device Law

JUNE 13, 2023

In the “ 50-State Survey of State Court Decisions Supporting Expert-Related Judicial Gatekeeping ,” the Drug & Device Law Blog (the Best Blog on the Planet) describes West Virginia as a “gatekeeper” state because of cases reflecting adoption of the Daubert analysis of W. 702 by the Supreme Court of Appeals of West Virginia.

Testimonials 59

Testimonials Science Trials International 59

Drug & Device Law

JUNE 6, 2023

So, we could not resist blogging about a Texas court reaching the exact opposite conclusion. So, at most plaintiff had her experts’ testimony that defendant did not do enough testing. Earlier this year we posted about an excellent magistrate decision in Baksic v. Ethicon Inc., 2023 WL 1192538 (Mag.

Testimonials 59

Testimonials FDA Production 59

Drug & Device Law

FEBRUARY 20, 2023

7, 2022), which addressed the same question in the context of the admissibility of expert testimony. Therefore, Davis excluded as “not relevant” expert testimony about non-FDA-approved alternatives. His testimony is thus irrelevant and inadmissible. Well, that’s what the Blog is here for – and that’s what prompted this post.

FDA 59

FDA FDA Approval Testimonials Vaccine 59

Drug & Device Law

DECEMBER 28, 2022

It is hard to beat Bexis’s lists of the best and worst DDL cases, the latter of which graced us last week , and the former of which will adorn this blog tomorrow, for inventorying what happened and what mattered in our area of the law in 2022. But it really is folly to plan the future without learning from the past.

Science 59

Science FDA Testimonials Hospitals 59

Drug & Device Law

DECEMBER 27, 2022

What follows is from the non-Dechert side of the Blog. Reliance on “animal data” – another notorious and frequent error common in unreliable expert testimony. 3d 1152 (S.D. Relying on the grossly excessive ranitidine exposure lab tests previously excluded for their bizarre results and shoddy methodologies.

Laboratories 59

Laboratories FDA Production International 59

Drug & Device Law

DECEMBER 5, 2022

The Blog examined the excesses of such litigation here , here , and here , among other posts. 239, 253 (2012) (which the Blog discussed here ). The Superior Court here “credited testimony from doctors who never implanted mesh, or who did so outside the state of California.” Fox Television Stations, Inc. , Petition at 13.

Testimonials 64

Testimonials Doctors Production Trials 64